Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Guldsmed Nicolaisen ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6%   Bankruptcy risk   1.2% 1.1% 1.2% 1.0% 1.0% 4.0% 9.6% 9.4%   Credit score (0-100)   85 85 83 85 88 49 26 26   Credit rating   A A A A A BBB BB BB   Credit limit (kDKK)   140.0 178.6 193.8 286.3 332.6 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,654 4,862 5,172 5,074 5,235 3,076 0.0 0.0   EBITDA   1,283 1,483 2,378 1,963 1,564 -336 0.0 0.0   EBIT   1,254 1,456 2,370 1,951 1,552 -363 0.0 0.0   Pre-tax profit (PTP)   1,221.5 1,453.0 2,378.6 1,938.8 1,557.0 -363.0 0.0 0.0   Net earnings   951.7 1,128.9 1,854.3 1,508.9 1,205.4 -296.1 0.0 0.0   Pre-tax profit without non-rec. items   1,222 1,453 2,379 1,939 1,557 -363 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   36.7 9.8 37.1 29.8 76.6 49.3 0.0 0.0   Shareholders equity total   3,103 2,632 3,736 3,745 3,451 2,280 2,155 2,155   Interest-bearing liabilities   0.0 0.0 0.1 92.3 371 2,084 0.0 0.0   Balance sheet total (assets)   4,976 5,197 7,528 6,360 6,396 6,418 2,155 2,155   Net Debt   -491 -1,187 -1,327 -156 215 1,997 -2,155 -2,155     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,654 4,862 5,172 5,074 5,235 3,076 0.0 0.0   Gross profit growth   -1.5% 4.5% 6.4% -1.9% 3.2% -41.2% -100.0% 0.0%   Employees   8 8 8 8 9 8 0 0   Employee growth %   -20.0% 0.0% 0.0% 0.0% 12.5% -11.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,976 5,197 7,528 6,360 6,396 6,418 2,155 2,155   Balance sheet change%   -17.4% 4.4% 44.9% -15.5% 0.6% 0.4% -66.4% 0.0%   Added value   1,283.2 1,482.6 2,377.9 1,962.6 1,564.4 -335.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -58 -54 19 -19 36 -55 -49 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   26.9% 29.9% 45.8% 38.4% 29.7% -11.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   22.8% 28.6% 37.6% 28.4% 24.8% -5.0% 0.0% 0.0%   ROI %   34.8% 48.9% 69.0% 47.0% 39.4% -7.9% 0.0% 0.0%   ROE %   30.4% 39.4% 58.2% 40.3% 33.5% -10.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   62.4% 50.6% 49.6% 58.9% 54.0% 35.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -38.3% -80.1% -55.8% -7.9% 13.7% -594.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 2.5% 10.8% 91.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   11.7% 0.0% 33,400.0% 79.1% 9.7% 3.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   0.6 0.6 0.9 0.8 0.5 0.2 0.0 0.0   Current Ratio   2.8 2.1 2.2 2.8 2.3 1.6 0.0 0.0   Cash and cash equivalent   491.4 1,187.4 1,326.8 247.9 156.4 87.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,078.2 2,615.3 4,052.9 3,969.9 3,450.2 2,295.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   160 185 297 245 174 -42 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   160 185 297 245 174 -42 0 0   EBIT / employee   157 182 296 244 172 -45 0 0   Net earnings / employee   119 141 232 189 134 -37 0 0